• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    3.26 Down 0.06(1.81%) 4:00PM EDT
    |After Hours : 3.26 0.00 (0.00%) 4:41PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 4,602   10,987   25,842   6,826  
    Cost of Revenue7  1,346   -  15  
    Gross Profit 4,595   9,641   25,842   6,811  
    Operating Expenses
    Research Development19,047  20,067  16,524  17,120  
    Selling General and Administrative2,721  2,731  3,534  4,061  
    Non Recurring21  5  442  60  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (17,194) (13,162) 5,342   (14,430)
    Income from Continuing Operations
    Total Other Income/Expenses Net397  (218)865  581  
    Earnings Before Interest And Taxes(16,797)(13,380)6,207  (13,849)
    Interest Expense1,338  1,241  1,306  1,315  
    Income Before Tax(18,135)(14,621)4,901  (15,164)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(18,135)(14,621)4,901  (15,164)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (18,135) (14,621) 4,901   (15,164)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (18,135) (14,621) 4,901   (15,164)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.